Evonik Industries (EVK) Stock Rating Reaffirmed by DZ Bank

DZ Bank reiterated their buy rating on shares of Evonik Industries (FRA:EVK) in a research report released on Wednesday.

Several other equities analysts also recently weighed in on the company. Baader Bank set a €38.00 ($46.91) price objective on Evonik Industries and gave the company a buy rating in a research note on Tuesday, February 6th. UBS Group set a €28.00 ($34.57) price objective on Evonik Industries and gave the company a sell rating in a research note on Monday, February 5th. Barclays set a €37.00 ($45.68) price objective on Evonik Industries and gave the company a buy rating in a research note on Wednesday, January 24th. JPMorgan Chase & Co. set a €25.00 ($30.86) price objective on Evonik Industries and gave the company a sell rating in a research note on Wednesday, January 17th. Finally, Societe Generale set a €39.00 ($48.15) price objective on Evonik Industries and gave the company a buy rating in a research note on Thursday, January 11th. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the stock. Evonik Industries has a consensus rating of Hold and an average price target of €34.00 ($41.98).

Evonik Industries (FRA EVK) opened at €30.07 ($37.12) on Wednesday. Evonik Industries has a one year low of €26.78 ($33.06) and a one year high of €32.97 ($40.70). The firm has a market capitalization of $13,970.00 and a P/E ratio of 19.15.

TRADEMARK VIOLATION NOTICE: “Evonik Industries (EVK) Stock Rating Reaffirmed by DZ Bank” was published by BBNS and is the property of of BBNS. If you are accessing this piece on another website, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this piece can be viewed at https://baseballnewssource.com/markets/evonik-industries-evk-stock-rating-reaffirmed-by-dz-bank/1887421.html.

Evonik Industries Company Profile

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish


Leave a Reply

 
© 2006-2018 BBNS.